<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-25155" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Migratory Thrombophlebitis</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Jinna</surname>
            <given-names>Sruthi</given-names>
          </name>
          <aff>Beaumont Health</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Khoury</surname>
            <given-names>John</given-names>
          </name>
          <aff>Oakland University/William Beaumont SOM</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Sruthi Jinna declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>John Khoury declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>26</day>
          <month>9</month>
          <year>2022</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-25155.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Migratory thrombophlebitis or thrombophlebitis migrans is an inflammatory reaction of the vein accompanied by a thrombus. It is characterized by the involvement of one vein group first, then improving and followed by the involvement of other vein groups. This activity reviews the etiology, evaluation, and management of migratory thrombophlebitis and highlights the role of an interprofessional team in improving care for patients with this condition.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Evaluate&#x000a0;the etiology of migratory thrombophlebitis.</p></list-item><list-item><p>Determine&#x000a0;the appropriate history, physical exam findings, and evaluation of migratory thrombophlebitis.</p></list-item><list-item><p>Differentiate&#x000a0;the treatment and management options available for migratory thrombophlebitis.</p></list-item><list-item><p>Communicate&#x000a0;the importance of an interprofessional team working together to facilitate care coordination and communication to improve outcomes.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=25155&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=25155">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-25155.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Thrombophlebitis is an inflammatory reaction of the vein accompanied by a thrombus. Migratory thrombophlebitis or thrombophlebitis migrans is characterized by the involvement&#x000a0;of&#x000a0;1 vein group first, then improving and followed by the involvement of other vein groups (see <bold>Image</bold>. Migratory Thrombophlebitis). Sometimes, several veins in different locations can be involved simultaneously. Both superficial and deep veins may be affected.</p>
      </sec>
      <sec id="article-25155.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>Superficial migratory thrombophlebitis is associated with systemic diseases like hypertension,<xref ref-type="bibr" rid="article-25155.r1">[1]</xref> Buerger syndrome/thrombophlebitis obliterans,<xref ref-type="bibr" rid="article-25155.r2">[2]</xref><xref ref-type="bibr" rid="article-25155.r3">[3]</xref> hypercoagulable conditions like protein C, S deficiencies, lupus anticoagulant,<xref ref-type="bibr" rid="article-25155.r4">[4]</xref> factor XII deficiency,<xref ref-type="bibr" rid="article-25155.r5">[5]</xref> inflammatory bowel disease,<xref ref-type="bibr" rid="article-25155.r6">[6]</xref> Behcet disease,<xref ref-type="bibr" rid="article-25155.r7">[7]</xref>&#x000a0;and pancreatic cancer. There are also reports of a cannabis smoker and a patient with Q fever.<xref ref-type="bibr" rid="article-25155.r8">[8]</xref><xref ref-type="bibr" rid="article-25155.r9">[9]</xref><xref ref-type="bibr" rid="article-25155.r8">[8]</xref></p>
        <p>Armand Trousseau first noted the association of superficial migratory thrombophlebitis and visceral malignancy in 1865. Based on history, Trousseau syndrome is characterized by unexplained thrombotic events that occur before the diagnosis of an occult visceral malignancy or appear concomitantly with cancer.<xref ref-type="bibr" rid="article-25155.r10">[10]</xref><xref ref-type="bibr" rid="article-25155.r11">[11]</xref> In patients with cancer, deep veins are also involved, and pulmonary embolism is a frequent complication.<xref ref-type="bibr" rid="article-25155.r12">[12]</xref> Unusual venous sites like upper extremities, trunk, and chest wall are involved.<xref ref-type="bibr" rid="article-25155.r11">[11]</xref> The characteristic presentation demonstrates the absence of predisposing factors like extreme old age, obesity, postoperative state, immobility, morbidity, varicose veins, and local trauma.</p>
      </sec>
      <sec id="article-25155.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>Idiopathic thrombophlebitis migrans occurs between the ages of 25 and 50; the average age is about 40. Men are affected&#x000a0;3 times more than women, which occurs in otherwise healthy adults.<xref ref-type="bibr" rid="article-25155.r10">[10]</xref><xref ref-type="bibr" rid="article-25155.r13">[13]</xref></p>
        <p>Virtually all cancers have correlations with migratory thrombophlebitis. Different series have reported different frequencies of cancer types associated with migratory thrombophlebitis.&#x000a0;Some reported a high incidence in the pancreatic body and tail carcinomas, and few others reported a higher incidence of lung adenocarcinomas in males and malignancy of the reproductive tract in females.<xref ref-type="bibr" rid="article-25155.r10">[10]</xref><xref ref-type="bibr" rid="article-25155.r14">[14]</xref><xref ref-type="bibr" rid="article-25155.r15">[15]</xref> Most commonly, it accompanies gastrointestinal (including pancreas and gastric), lung, and urogenital cancers.<xref ref-type="bibr" rid="article-25155.r16">[16]</xref></p>
      </sec>
      <sec id="article-25155.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>Phlebitic syndrome in association with cancer is distinctive, and its pathogenesis is not well understood. Research has reported the spectrum of overlapping mechanisms in Trousseau syndrome.<xref ref-type="bibr" rid="article-25155.r11">[11]</xref> Early reports noted that Trousseau syndrome commonly occurs in mucin-producing adenocarcinomas; however, not all cases correlate with mucin-producing carcinomas.<xref ref-type="bibr" rid="article-25155.r16">[16]</xref>&#x000a0;Mucins are highly glycosylated glycoproteins secreted by epithelial cells. In patients with carcinomas, mucins are aberrantly glycosylated and get inappropriately secreted into the blood; the liver clears the bulk of these mucins, and a small fraction is resistant. These mucins interact with L-selectin adhesion molecules expressed on leukocytes and P-selection adhesion molecules expressed on platelet and endothelial cells, producing platelet-rich microthrombi.<xref ref-type="bibr" rid="article-25155.r16">[16]</xref></p>
        <p>Reports exist of tissue factor (TF) as a cause of Trousseau syndrome. Cancer cells express abnormally high TF and release TF-positive microparticles that are highly procoagulant.<xref ref-type="bibr" rid="article-25155.r17">[17]</xref> Inflammatory cytokines produced by cancer cells induce TF expression in vascular cells, where it does not usually get expressed. Cancer cells also induce monocytes and macrophages to release TF. TF promotes the conversion of factor VII to factor VIIa, activating the coagulation cascade's extrinsic pathway.<xref ref-type="bibr" rid="article-25155.r18">[18]</xref><xref ref-type="bibr" rid="article-25155.r19">[19]</xref><xref ref-type="bibr" rid="article-25155.r20">[20]</xref>&#x000a0;Cancer procoagulant, also described as cysteine proteinase, expressed by malignant cells and normal cells (except fetal tissue), directly induces the conversion of factor X to factor Xa.<xref ref-type="bibr" rid="article-25155.r21">[21]</xref>&#x000a0;There are reports that hypoxia increases the expression of TF and plasminogen activator inhibitor type1 that facilitates coagulation.<xref ref-type="bibr" rid="article-25155.r22">[22]</xref></p>
      </sec>
      <sec id="article-25155.s6" sec-type="Histopathology">
        <title>Histopathology</title>
        <p>Infiltration of the vascular wall by inflammatory infiltrates like neutrophils, eosinophils, histiocytes, lymphocytes, and giant cells. The presence of organized thrombus within the lumen in the initial phase is replaced by recanalization and fibrosis later. Orcein staining reveals the absence of the internal elastic lamia.<xref ref-type="bibr" rid="article-25155.r23">[23]</xref></p>
        <p>The primary histopathological differential diagnosis of superficial migratory thrombophlebitis is polyarteritis nodosa, a condition in which arteries are involved, recognized by the diameter of the lumen, the thickness of the wall, and the presence of an internal elastic lumen.<xref ref-type="bibr" rid="article-25155.r24">[24]</xref>&#x000a0;In Trousseau syndrome, there is no invasion of the affected vein by tumor or tumor emboli, and there is usually a little inflammatory reaction.<xref ref-type="bibr" rid="article-25155.r16">[16]</xref>&#x000a0;Buerger disease demonstrates characteristic inflammation and thrombosis of small and medium-sized arteries and veins and the presence of giant cells and microabscesses within thrombi.<xref ref-type="bibr" rid="article-25155.r25">[25]</xref></p>
      </sec>
      <sec id="article-25155.s7" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>As superficial migratory thrombophlebitis is associated with other systemic disorders, it is important to obtain a detailed history to identify symptoms and signs of an underlying disorder. Ask for a history of hypertension, smoking, and cannabis ab, travel history, personal and family history of cancer, hypercoagulable disorders, and autoimmune disorders. To evaluate the migratory nature, ask if the patient has similar prior episodes and the location of the involved vein.</p>
        <p>
<bold>Clinical presentation</bold>
</p>
        <p>Patients with superficial thrombophlebitis present with pain, erythema, and induration along the course of a superficial vein. Due to a thrombus within the affected vein, a nodular cord is often palpable. A fever might be present. Evaluate for signs and symptoms of deep venous thrombosis and pulmonary embolism in high-risk patients, such as those older than 60, male sex, presence of systemic infection, bilateral superficial vein thromboses, and absence of varicose veins. Mondor disease is superficial thrombophlebitis of the epigastric, thoracoepigastric, or lateral thoracic veins, presenting as painful indurated erythematous cords.<xref ref-type="bibr" rid="article-25155.r26">[26]</xref> There are also some reports of it appearing in the axilla, penis, and the inguinal region as well.<xref ref-type="bibr" rid="article-25155.r27">[27]</xref></p>
      </sec>
      <sec id="article-25155.s8" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>Superficial thrombophlebitis is a clinical diagnosis. The patient usually presents with pain and erythema at the involved site. On palpation, the vein is hard and tender. Brownish discoloration or hyperpigmentation from hemosiderin deposition can present through previously affected veins. Extensive limb swelling can occur in the presence of deep venous thrombosis.<xref ref-type="bibr" rid="article-25155.r28">[28]</xref><xref ref-type="bibr" rid="article-25155.r29">[29]</xref></p>
        <p>
<bold>Indications for Duplex Ultrasound (US)</bold>
</p>
        <p>Indicate the use of duplex ultrasound in patients with pain along the course of the superficial vein but who have no physical exam findings suggestive of thrombophlebitis. In obese patients, superficial veins are located several centimeters below the normal-appearing skin surface; these patients may have superficial or deep venous thrombosis. Duplex ultrasound is also indicated in these patients to rule out DVT.<xref ref-type="bibr" rid="article-25155.r30">[30]</xref>&#x000a0;Superficial venous thrombosis involves a great saphenous vein and a small saphenous vein, at high risk of progression to deep vein thrombosis. If the patient has thrombophlebitis involving these veins, perform a duplex ultrasound to evaluate the extension of the thrombus.<xref ref-type="bibr" rid="article-25155.r31">[31]</xref><xref ref-type="bibr" rid="article-25155.r32">[32]</xref>&#x000a0;Patients with significant extremity swelling should have a duplex ultrasound to rule out DVT. Diagnosis of migratory thrombophlebitis is essential, as it correlates with cancer and other systemic disorders and can be the initial presentation of underlying occult malignancy [33]. Cancer can manifest months and even years after superficial migratory thrombophlebitis is diagnosed. These patients should undergo evaluation for underlying malignancy and other systemic disorders when superficial migratory thrombophlebitis is diagnosed.</p>
        <p>A comprehensive survey includes:</p>
        <list list-type="bullet">
          <list-item>
            <p>A complete history to evaluate symptoms and signs of cancer</p>
          </list-item>
          <list-item>
            <p>A thorough physical examination, including a digital rectal examination, testing for fetal occult blood, and pelvic examination in women</p>
          </list-item>
          <list-item>
            <p>Laboratory testing, including complete blood count with peripheral smear, basic metabolic panel, liver function tests, erythrocyte sedimentation rate, urinalysis, tumor markers, autoimmune workup, and studies for hypercoagulability</p>
          </list-item>
          <list-item>
            <p>Chest radiograph</p>
          </list-item>
          <list-item>
            <p>A chest, abdominal, and pelvic CT scan</p>
          </list-item>
          <list-item>
            <p>Age-appropriate cancer screening, including mammography and a Papanicolaou smear in women, upper and lower GI tract evaluation</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-25155.s9" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>The treatment goal is to relieve local symptoms and prevent the propagation of the thrombus. Supportive care includes elevating the affected extremity, taking nonsteroidal anti-inflammatory drugs, applying a warm or cold compress, wearing compression stockings, and increasing ambulation. Supportive care is indicated in patients with superficial thrombophlebitis involving a vein segment of size less than 5 cm, a thrombus site remote from the saphenofemoral and saphenopopliteal junction, and no medical risk factors for venous thromboembolism. These patients are followed up in 7 to 10 days or sooner if symptoms progress, and if no clinical improvement in symptoms is observed, an ultrasound duplex is performed to rule out deep vein thrombosis.</p>
        <p>Anticoagulation is indicated in patients with clot propagation, in high-risk patients with thrombus longer than 5 cm and within 5 cm from the saphenofemoral junction or saphenopopliteal junction, and in patients with concomitant deep venous thrombosis and pulmonary embolism.&#x000a0;The choice of anticoagulation agent and its dose and duration of treatment remain debated. In patients with superficial venous thrombosis, an intermediate subcutaneous dose of low-molecular-weight heparin, like enoxaparin 40 mg daily, dalteparin 5000 units every 12 hours, subcutaneous fondaparinux 2.5 mg daily, or oral rivaroxaban 10 mg daily is suggested for 45 days.<xref ref-type="bibr" rid="article-25155.r33">[33]</xref><xref ref-type="bibr" rid="article-25155.r34">[34]</xref><xref ref-type="bibr" rid="article-25155.r35">[35]</xref><xref ref-type="bibr" rid="article-25155.r36">[36]</xref>&#x000a0;Long-duration anticoagulation is the recommended course for patients with deep venous thrombosis and pulmonary embolism. In patients with contraindications to anticoagulation, the recommendation is to ligate the saphenous vein at a saphenofemoral or saphenopopliteal junction. In patients with Trousseau syndrome, heparin is the choice of anticoagulation. Heparin inactivates the thrombin and activates factor Xa, interrupting secondary platelet activation and fluid-phase thrombosis.<xref ref-type="bibr" rid="article-25155.r11">[11]</xref><xref ref-type="bibr" rid="article-25155.r37">[37]</xref><xref ref-type="bibr" rid="article-25155.r20">[20]</xref>&#x000a0;Migratory thrombophlebitis can be resistant to anticoagulation treatment in cancer patients, resulting in the progression of thrombus and recurrent pulmonary embolism.<xref ref-type="bibr" rid="article-25155.r15">[15]</xref>&#x000a0;There are reports in patients with malignancy and migratory thrombophlebitis that surgical removal of cancer results in cancer cure and also improves phlebitis symptoms and reduces thrombotic events<xref ref-type="bibr" rid="article-25155.r38">[38]</xref><xref ref-type="bibr" rid="article-25155.r39">[39]</xref>&#x000a0;The clinician should strongly recommend smoking cessation in patients with Buerger disease.</p>
      </sec>
      <sec id="article-25155.s10" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>Differential diagnoses include cellulitis, lymphangitis, erythema nodosum, nodular vasculitis, and polyarteritis nodosa.<xref ref-type="bibr" rid="article-25155.r12">[12]</xref><xref ref-type="bibr" rid="article-25155.r23">[23]</xref> Superficial migratory thrombophlebitis should be included in the differential when evaluating patients with these conditions. Palpable cord-like nodules and a linear and serpiginous pattern of the purpura are distinguishing features of superficial migratory thrombophlebitis.<xref ref-type="bibr" rid="article-25155.r40">[40]</xref></p>
      </sec>
      <sec id="article-25155.s11" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>The prognosis for migratory thrombophlebitis depends on the cause. For malignancies, the prognosis is poor. For benign disorders, the prognosis is good, but residual post-phlebitic syndrome is an issue. Patients require compression stockings for life to prevent postphlebitic syndrome. Those who have a blood clot need anticoagulation therapy for 3 to 9 months. For those who do not seek treatment, pulmonary embolism can prove to be fatal.</p>
      </sec>
      <sec id="article-25155.s12" sec-type="Complications">
        <title>Complications</title>
        <p>The frequent complication is the extension of a thrombus, which can result in deep vein thrombus and pulmonary embolism, and the risk is as high as 18%.<xref ref-type="bibr" rid="article-25155.r31">[31]</xref><xref ref-type="bibr" rid="article-25155.r41">[41]</xref><xref ref-type="bibr" rid="article-25155.r29">[29]</xref> Veins in unusual locations like the neck and abdominal viscera might be involved.<xref ref-type="bibr" rid="article-25155.r13">[13]</xref>&#x000a0;Other complications include chronic edema and chronic venous ulcers.</p>
      </sec>
      <sec id="article-25155.s13" sec-type="Consultations">
        <title>Consultations</title>
        <p>In patients with migratory thrombophlebitis, consulting a hematology-oncologist is recommended. In patients with indications for surgical ligation, a consultation with a vascular surgeon is the recommended course of action.</p>
      </sec>
      <sec id="article-25155.s14" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>Educate the patients regarding thrombophlebitis's migratory and recurrent nature and encourage them to follow up to evaluate any further underlying systemic disorders and malignancy.</p>
      </sec>
      <sec id="article-25155.s15" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Diagnosis and management of migratory thrombophlebitis require an interprofessional team of healthcare professionals, including primary care providers, dermatologists, pharmacists, vascular surgeons, ultrasound technicians, and hematology-oncologists, working together to achieve better patient outcomes. Most patients with thrombophlebitis first present to the primary care providers. These clinicians should order a duplex ultrasound to rule out a blood clot. If the phlebitis is recurrent and migratory, the onus is on the clinicians to search for malignancy. A referral to the internist or oncologist is recommended. While the patient is being worked up, the pharmacist should educate the patient on medication compliance if the clinician discovers a clot in the deep veins. The pharmacist should also verify the dosing and administration of anticoagulant therapy and report any concerns to the prescriber. Also, the patient should be educated&#x000a0;on the importance of wearing compression stockings to prevent post-phlebitic syndrome and evaluate therapeutic results at each follow-up visit. Even when the primary cause of thrombophlebitis gets diagnosed and treated, phlebitis itself also requires treatment. Failing to administer anticoagulation for deep vein thrombosis can result in pulmonary embolism and medical malpractice. The interprofessional healthcare team must collaborate and communicate when looking after the patient to obtain the best outcomes.</p>
      </sec>
      <sec id="article-25155.s16">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=25155&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=25155">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/blood-disorders/migratory-thrombophlebitis/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=25155">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/25155/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=25155">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <floats-group id="article-25155.s17">
        <fig id="article-25155.image.f1" position="float" orientation="portrait">
          <caption>
            <p>Migratory Thrombophlebitis Contributed by&#x000a0;S Bhimji, MD</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="migratory__thrombophlebitis" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <ref-list id="article-25155.s18">
        <title>References</title>
        <ref id="article-25155.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Laguna</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>P&#x000e9;rez-Ferriols</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Alegre</surname>
                <given-names>V</given-names>
              </name>
            </person-group>
            <article-title>Superficial migratory thrombophlebitis in a hypertensive patient: response to antihypertensive therapy.</article-title>
            <source>J Eur Acad Dermatol Venereol</source>
            <year>2008</year>
            <month>Mar</month>
            <volume>22</volume>
            <issue>3</issue>
            <fpage>383</fpage>
            <page-range>383-4</page-range>
            <pub-id pub-id-type="pmid">18269615</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25155.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pe&#x000f1;a-penabad</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Mart&#x000ed;nez</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>del Pozo</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Garc&#x000ed;a-Silva</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Yebra</surname>
                <given-names>MT</given-names>
              </name>
              <name>
                <surname>Fonseca</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>Guess what! Superficial migratory thrombophlebitis. Thromboangiitis obliterans (Buerger's disease).</article-title>
            <source>Eur J Dermatol</source>
            <year>2000</year>
            <season>Jul-Aug</season>
            <volume>10</volume>
            <issue>5</issue>
            <fpage>405</fpage>
            <page-range>405-6</page-range>
            <pub-id pub-id-type="pmid">11023339</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25155.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>VILANOVA</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>MORAGAS</surname>
                <given-names>JM</given-names>
              </name>
            </person-group>
            <article-title>[Thrombophlebitis migrans: first apparent sign of thromboangiitis obliterans].</article-title>
            <source>Actas Dermosifiliogr</source>
            <year>1952</year>
            <month>Jun</month>
            <volume>43</volume>
            <issue>9</issue>
            <fpage>812</fpage>
            <page-range>812-3</page-range>
            <pub-id pub-id-type="pmid">12985470</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25155.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Blum</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Gilkeson</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Greenberg</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Murray</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Superficial migratory thrombophlebitis and the lupus anticoagulant.</article-title>
            <source>Int J Dermatol</source>
            <year>1990</year>
            <month>Apr</month>
            <volume>29</volume>
            <issue>3</issue>
            <fpage>190</fpage>
            <page-range>190-2</page-range>
            <pub-id pub-id-type="pmid">2110553</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25155.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Samlaska</surname>
                <given-names>CP</given-names>
              </name>
              <name>
                <surname>James</surname>
                <given-names>WD</given-names>
              </name>
              <name>
                <surname>Simel</surname>
                <given-names>DL</given-names>
              </name>
            </person-group>
            <article-title>Superficial migratory thrombophlebitis and factor XII deficiency.</article-title>
            <source>J Am Acad Dermatol</source>
            <year>1990</year>
            <month>May</month>
            <volume>22</volume>
            <issue>5 Pt 2</issue>
            <fpage>939</fpage>
            <page-range>939-43</page-range>
            <pub-id pub-id-type="pmid">2110579</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25155.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Iyer</surname>
                <given-names>SK</given-names>
              </name>
              <name>
                <surname>Handler</surname>
                <given-names>LJ</given-names>
              </name>
              <name>
                <surname>Johnston</surname>
                <given-names>JS</given-names>
              </name>
            </person-group>
            <article-title>Thrombophlebitis migrans in association with ulcerative colitis.</article-title>
            <source>J Natl Med Assoc</source>
            <year>1981</year>
            <month>Oct</month>
            <volume>73</volume>
            <issue>10</issue>
            <fpage>987</fpage>
            <page-range>987-9</page-range>
            <pub-id pub-id-type="pmid">7310913</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25155.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chajek</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Fainaru</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Beh&#x000e7;et's disease. Report of 41 cases and a review of the literature.</article-title>
            <source>Medicine (Baltimore)</source>
            <year>1975</year>
            <month>May</month>
            <volume>54</volume>
            <issue>3</issue>
            <fpage>179</fpage>
            <page-range>179-96</page-range>
            <pub-id pub-id-type="pmid">1095889</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25155.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Fern&#x000e1;ndez Guerrero</surname>
                <given-names>ML</given-names>
              </name>
              <name>
                <surname>Rivas</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Garc&#x000ed;a Delgado</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Migratory thrombophlebitis and acute Q fever.</article-title>
            <source>Emerg Infect Dis</source>
            <year>2004</year>
            <month>Mar</month>
            <volume>10</volume>
            <issue>3</issue>
            <fpage>546</fpage>
            <page-range>546-7</page-range>
            <pub-id pub-id-type="pmid">15116709</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25155.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lee</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Moll</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Migratory superficial thrombophlebitis in a cannabis smoker.</article-title>
            <source>Circulation</source>
            <year>2014</year>
            <month>Jul</month>
            <day>08</day>
            <volume>130</volume>
            <issue>2</issue>
            <fpage>214</fpage>
            <page-range>214-5</page-range>
            <pub-id pub-id-type="pmid">25001627</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25155.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>GROSS</surname>
                <given-names>FB</given-names>
              </name>
              <name>
                <surname>JAEHNING</surname>
                <given-names>DG</given-names>
              </name>
              <name>
                <surname>COKER</surname>
                <given-names>WG</given-names>
              </name>
            </person-group>
            <article-title>The association of migratory thrombophlebitis with carcinoma.</article-title>
            <source>N C Med J</source>
            <year>1951</year>
            <month>Mar</month>
            <volume>12</volume>
            <issue>3</issue>
            <fpage>97</fpage>
            <page-range>97-101</page-range>
            <pub-id pub-id-type="pmid">14827321</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25155.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Varki</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Trousseau's syndrome: multiple definitions and multiple mechanisms.</article-title>
            <source>Blood</source>
            <year>2007</year>
            <month>Sep</month>
            <day>15</day>
            <volume>110</volume>
            <issue>6</issue>
            <fpage>1723</fpage>
            <page-range>1723-9</page-range>
            <pub-id pub-id-type="pmid">17496204</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25155.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lesher</surname>
                <given-names>JL</given-names>
              </name>
            </person-group>
            <article-title>Superficial migratory thrombophlebitis.</article-title>
            <source>Cutis</source>
            <year>1991</year>
            <month>Mar</month>
            <volume>47</volume>
            <issue>3</issue>
            <fpage>177</fpage>
            <page-range>177-80</page-range>
            <pub-id pub-id-type="pmid">2022126</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25155.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>FISCHER</surname>
                <given-names>EH</given-names>
              </name>
            </person-group>
            <article-title>Thrombophlebitis migrans.</article-title>
            <source>J Kans Med Soc</source>
            <year>1946</year>
            <month>Jun</month>
            <volume>47</volume>
            <fpage>245</fpage>
            <page-range>245-9</page-range>
            <pub-id pub-id-type="pmid">20986053</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25155.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>LIEBERMAN</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>BORRERO</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>URDANETA</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>WRIGHT</surname>
                <given-names>IS</given-names>
              </name>
            </person-group>
            <article-title>Thrombophlebitis and cancer.</article-title>
            <source>JAMA</source>
            <year>1961</year>
            <month>Aug</month>
            <day>26</day>
            <volume>177</volume>
            <fpage>542</fpage>
            <page-range>542-5</page-range>
            <pub-id pub-id-type="pmid">13762005</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25155.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>SMITH</surname>
                <given-names>EK</given-names>
              </name>
            </person-group>
            <article-title>MULTIPLE MIGRATORY THROMBOPHLEBITIS IN MALIGNANT DISEASE.</article-title>
            <source>Guys Hosp Rep</source>
            <year>1964</year>
            <volume>113</volume>
            <fpage>91</fpage>
            <page-range>91-5</page-range>
            <pub-id pub-id-type="pmid">14157987</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25155.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Oster</surname>
                <given-names>MW</given-names>
              </name>
            </person-group>
            <article-title>Thrombophlebitis and cancer. A review.</article-title>
            <source>Angiology</source>
            <year>1976</year>
            <month>Oct</month>
            <volume>27</volume>
            <issue>10</issue>
            <fpage>557</fpage>
            <page-range>557-67</page-range>
            <pub-id pub-id-type="pmid">802883</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25155.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Geddings</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>Mackman</surname>
                <given-names>N</given-names>
              </name>
            </person-group>
            <article-title>Tumor-derived tissue factor-positive microparticles and venous thrombosis in cancer patients.</article-title>
            <source>Blood</source>
            <year>2013</year>
            <month>Sep</month>
            <day>12</day>
            <volume>122</volume>
            <issue>11</issue>
            <fpage>1873</fpage>
            <page-range>1873-80</page-range>
            <pub-id pub-id-type="pmid">23798713</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25155.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Callander</surname>
                <given-names>NS</given-names>
              </name>
              <name>
                <surname>Varki</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Rao</surname>
                <given-names>LV</given-names>
              </name>
            </person-group>
            <article-title>Immunohistochemical identification of tissue factor in solid tumors.</article-title>
            <source>Cancer</source>
            <year>1992</year>
            <month>Sep</month>
            <day>01</day>
            <volume>70</volume>
            <issue>5</issue>
            <fpage>1194</fpage>
            <page-range>1194-201</page-range>
            <pub-id pub-id-type="pmid">1381270</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25155.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Van Dreden</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>&#x00395;lalamy</surname>
                <given-names>&#x00399;</given-names>
              </name>
              <name>
                <surname>Gerotziafas</surname>
                <given-names>GT</given-names>
              </name>
            </person-group>
            <article-title>The Role of Tissue Factor in Cancer-Related Hypercoagulability, Tumor Growth, Angiogenesis and Metastasis and Future Therapeutic Strategies.</article-title>
            <source>Crit Rev Oncog</source>
            <year>2017</year>
            <volume>22</volume>
            <issue>3-4</issue>
            <fpage>219</fpage>
            <page-range>219-248</page-range>
            <pub-id pub-id-type="pmid">29604900</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25155.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rao</surname>
                <given-names>LV</given-names>
              </name>
            </person-group>
            <article-title>Tissue factor as a tumor procoagulant.</article-title>
            <source>Cancer Metastasis Rev</source>
            <year>1992</year>
            <month>Nov</month>
            <volume>11</volume>
            <issue>3-4</issue>
            <fpage>249</fpage>
            <page-range>249-66</page-range>
            <pub-id pub-id-type="pmid">1423817</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25155.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Falanga</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Gordon</surname>
                <given-names>SG</given-names>
              </name>
            </person-group>
            <article-title>Isolation and characterization of cancer procoagulant: a cysteine proteinase from malignant tissue.</article-title>
            <source>Biochemistry</source>
            <year>1985</year>
            <month>Sep</month>
            <day>24</day>
            <volume>24</volume>
            <issue>20</issue>
            <fpage>5558</fpage>
            <page-range>5558-67</page-range>
            <pub-id pub-id-type="pmid">3935163</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25155.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Denko</surname>
                <given-names>NC</given-names>
              </name>
              <name>
                <surname>Giaccia</surname>
                <given-names>AJ</given-names>
              </name>
            </person-group>
            <article-title>Tumor hypoxia, the physiological link between Trousseau's syndrome (carcinoma-induced coagulopathy) and metastasis.</article-title>
            <source>Cancer Res</source>
            <year>2001</year>
            <month>Feb</month>
            <day>01</day>
            <volume>61</volume>
            <issue>3</issue>
            <fpage>795</fpage>
            <page-range>795-8</page-range>
            <pub-id pub-id-type="pmid">11221857</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25155.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Laguna</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Alegre</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>P&#x000e9;rez</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>[Superficial migratory thrombophlebitis: a clinical and histologic review of 8 cases].</article-title>
            <source>Actas Dermosifiliogr</source>
            <year>2008</year>
            <month>Jun</month>
            <volume>99</volume>
            <issue>5</issue>
            <fpage>390</fpage>
            <page-range>390-5</page-range>
            <pub-id pub-id-type="pmid">18501171</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25155.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chen</surname>
                <given-names>KR</given-names>
              </name>
            </person-group>
            <article-title>The misdiagnosis of superficial thrombophlebitis as cutaneous polyarteritis nodosa: features of the internal elastic lamina and the compact concentric muscular layer as diagnostic pitfalls.</article-title>
            <source>Am J Dermatopathol</source>
            <year>2010</year>
            <month>Oct</month>
            <volume>32</volume>
            <issue>7</issue>
            <fpage>688</fpage>
            <page-range>688-93</page-range>
            <pub-id pub-id-type="pmid">20647909</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25155.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tanaka</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Pathology and pathogenesis of Buerger's disease.</article-title>
            <source>Int J Cardiol</source>
            <year>1998</year>
            <month>Oct</month>
            <day>01</day>
            <volume>66 Suppl 1</volume>
            <fpage>S237</fpage>
            <page-range>S237-42</page-range>
            <pub-id pub-id-type="pmid">9951825</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25155.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Crisan</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Badea</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Crisan</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Thrombophlebitis of the lateral chest wall (Mondor's disease).</article-title>
            <source>Indian J Dermatol Venereol Leprol</source>
            <year>2014</year>
            <season>Jan-Feb</season>
            <volume>80</volume>
            <issue>1</issue>
            <fpage>96</fpage>
            <pub-id pub-id-type="pmid">24448146</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25155.r27">
          <label>27</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>&#x000d6;zt&#x000fc;rk</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Penile Mondor's disease.</article-title>
            <source>Basic Clin Androl</source>
            <year>2014</year>
            <volume>24</volume>
            <fpage>5</fpage>
            <pub-id pub-id-type="pmid">25780580</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25155.r28">
          <label>28</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Maddox</surname>
                <given-names>RP</given-names>
              </name>
              <name>
                <surname>Seupaul</surname>
                <given-names>RA</given-names>
              </name>
            </person-group>
            <article-title>What Is the Most Effective Treatment of Superficial Thrombophlebitis?</article-title>
            <source>Ann Emerg Med</source>
            <year>2016</year>
            <month>May</month>
            <volume>67</volume>
            <issue>5</issue>
            <fpage>671</fpage>
            <page-range>671-2</page-range>
            <pub-id pub-id-type="pmid">26707361</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25155.r29">
          <label>29</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nasr</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Scriven</surname>
                <given-names>JM</given-names>
              </name>
            </person-group>
            <article-title>Superficial thrombophlebitis (superficial venous thrombosis).</article-title>
            <source>BMJ</source>
            <year>2015</year>
            <month>Jun</month>
            <day>22</day>
            <volume>350</volume>
            <fpage>h2039</fpage>
            <pub-id pub-id-type="pmid">26099257</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25155.r30">
          <label>30</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Blumenberg</surname>
                <given-names>RM</given-names>
              </name>
              <name>
                <surname>Barton</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Gelfand</surname>
                <given-names>ML</given-names>
              </name>
              <name>
                <surname>Skudder</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Brennan</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Occult deep venous thrombosis complicating superficial thrombophlebitis.</article-title>
            <source>J Vasc Surg</source>
            <year>1998</year>
            <month>Feb</month>
            <volume>27</volume>
            <issue>2</issue>
            <fpage>338</fpage>
            <page-range>338-43</page-range>
            <pub-id pub-id-type="pmid">9510288</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25155.r31">
          <label>31</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lutter</surname>
                <given-names>KS</given-names>
              </name>
              <name>
                <surname>Kerr</surname>
                <given-names>TM</given-names>
              </name>
              <name>
                <surname>Roedersheimer</surname>
                <given-names>LR</given-names>
              </name>
              <name>
                <surname>Lohr</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Sampson</surname>
                <given-names>MG</given-names>
              </name>
              <name>
                <surname>Cranley</surname>
                <given-names>JJ</given-names>
              </name>
            </person-group>
            <article-title>Superficial thrombophlebitis diagnosed by duplex scanning.</article-title>
            <source>Surgery</source>
            <year>1991</year>
            <month>Jul</month>
            <volume>110</volume>
            <issue>1</issue>
            <fpage>42</fpage>
            <page-range>42-6</page-range>
            <pub-id pub-id-type="pmid">1866693</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25155.r32">
          <label>32</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Skillman</surname>
                <given-names>JJ</given-names>
              </name>
              <name>
                <surname>Kent</surname>
                <given-names>KC</given-names>
              </name>
              <name>
                <surname>Porter</surname>
                <given-names>DH</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Simultaneous occurrence of superficial and deep thrombophlebitis in the lower extremity.</article-title>
            <source>J Vasc Surg</source>
            <year>1990</year>
            <month>Jun</month>
            <volume>11</volume>
            <issue>6</issue>
            <fpage>818</fpage>
            <page-range>818-23; discussion 823-4</page-range>
            <pub-id pub-id-type="pmid">2193177</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25155.r33">
          <label>33</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Decousus</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Prandoni</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Mismetti</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Bauersachs</surname>
                <given-names>RM</given-names>
              </name>
              <name>
                <surname>Boda</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Brenner</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Laporte</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Matyas</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Middeldorp</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Sokurenko</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Leizorovicz</surname>
                <given-names>A</given-names>
              </name>
              <collab>CALISTO Study Group</collab>
            </person-group>
            <article-title>Fondaparinux for the treatment of superficial-vein thrombosis in the legs.</article-title>
            <source>N Engl J Med</source>
            <year>2010</year>
            <month>Sep</month>
            <day>23</day>
            <volume>363</volume>
            <issue>13</issue>
            <fpage>1222</fpage>
            <page-range>1222-32</page-range>
            <pub-id pub-id-type="pmid">20860504</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25155.r34">
          <label>34</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Di Nisio</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Wichers</surname>
                <given-names>IM</given-names>
              </name>
              <name>
                <surname>Middeldorp</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Treatment for superficial thrombophlebitis of the leg.</article-title>
            <source>Cochrane Database Syst Rev</source>
            <year>2018</year>
            <month>Feb</month>
            <day>25</day>
            <volume>2</volume>
            <issue>2</issue>
            <fpage>CD004982</fpage>
            <pub-id pub-id-type="pmid">29478266</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25155.r35">
          <label>35</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Duffett</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Kearon</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Rodger</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Carrier</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Treatment of Superficial Vein Thrombosis: A Systematic Review and Meta-Analysis.</article-title>
            <source>Thromb Haemost</source>
            <year>2019</year>
            <month>Mar</month>
            <volume>119</volume>
            <issue>3</issue>
            <fpage>479</fpage>
            <page-range>479-489</page-range>
            <pub-id pub-id-type="pmid">30716777</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25155.r36">
          <label>36</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wichers</surname>
                <given-names>IM</given-names>
              </name>
              <name>
                <surname>Di Nisio</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>B&#x000fc;ller</surname>
                <given-names>HR</given-names>
              </name>
              <name>
                <surname>Middeldorp</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Treatment of superficial vein thrombosis to prevent deep vein thrombosis and pulmonary embolism: a systematic review.</article-title>
            <source>Haematologica</source>
            <year>2005</year>
            <month>May</month>
            <volume>90</volume>
            <issue>5</issue>
            <fpage>672</fpage>
            <page-range>672-7</page-range>
            <pub-id pub-id-type="pmid">15921382</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25155.r37">
          <label>37</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Johnson</surname>
                <given-names>AC</given-names>
              </name>
              <name>
                <surname>Kurtides</surname>
                <given-names>ES</given-names>
              </name>
            </person-group>
            <article-title>Migratory thrombophlebitis. Heparin sodium vs. warfarin sodium therapy.</article-title>
            <source>IMJ Ill Med J</source>
            <year>1967</year>
            <month>Jan</month>
            <volume>131</volume>
            <issue>1</issue>
            <fpage>54</fpage>
            <page-range>54-6</page-range>
            <pub-id pub-id-type="pmid">4382849</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25155.r38">
          <label>38</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>WOMACK</surname>
                <given-names>WS</given-names>
              </name>
              <name>
                <surname>CASTELLANO</surname>
                <given-names>CJ</given-names>
              </name>
            </person-group>
            <article-title>Migratory thrombophlebitis associated with ovarian carcinoma.</article-title>
            <source>Am J Obstet Gynecol</source>
            <year>1952</year>
            <month>Feb</month>
            <volume>63</volume>
            <issue>2</issue>
            <fpage>467</fpage>
            <page-range>467-9</page-range>
            <pub-id pub-id-type="pmid">14894567</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25155.r39">
          <label>39</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>WOOLLING</surname>
                <given-names>KR</given-names>
              </name>
              <name>
                <surname>SHICK</surname>
                <given-names>RM</given-names>
              </name>
            </person-group>
            <article-title>Thrombophlebitis: a possible clue to cryptic malignant lesions.</article-title>
            <source>Proc Staff Meet Mayo Clin</source>
            <year>1956</year>
            <month>Apr</month>
            <day>18</day>
            <volume>31</volume>
            <issue>8</issue>
            <fpage>227</fpage>
            <page-range>227-33</page-range>
            <pub-id pub-id-type="pmid">13323038</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25155.r40">
          <label>40</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tian</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Mazurek</surname>
                <given-names>KR</given-names>
              </name>
              <name>
                <surname>Malinak</surname>
                <given-names>RN</given-names>
              </name>
              <name>
                <surname>Dean</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Kaffenberger</surname>
                <given-names>BH</given-names>
              </name>
            </person-group>
            <article-title>Pseudocellulitis Need Not be Benign: Three Cases of Superficial Migratory Thrombophlebitis with "Negative" Venous Duplex Ultrasonography.</article-title>
            <source>J Clin Aesthet Dermatol</source>
            <year>2017</year>
            <month>Dec</month>
            <volume>10</volume>
            <issue>12</issue>
            <fpage>49</fpage>
            <page-range>49-51</page-range>
            <pub-id pub-id-type="pmid">29399267</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25155.r41">
          <label>41</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chengelis</surname>
                <given-names>DL</given-names>
              </name>
              <name>
                <surname>Bendick</surname>
                <given-names>PJ</given-names>
              </name>
              <name>
                <surname>Glover</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Brown</surname>
                <given-names>OW</given-names>
              </name>
              <name>
                <surname>Ranval</surname>
                <given-names>TJ</given-names>
              </name>
            </person-group>
            <article-title>Progression of superficial venous thrombosis to deep vein thrombosis.</article-title>
            <source>J Vasc Surg</source>
            <year>1996</year>
            <month>Nov</month>
            <volume>24</volume>
            <issue>5</issue>
            <fpage>745</fpage>
            <page-range>745-9</page-range>
            <pub-id pub-id-type="pmid">8918318</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
